Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Tables)

v3.21.1
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2020
Discontinued Operations  
Schedule of discontinued operations and assets held for sale

 

 

 

 

 

 

December 31, 

 

    

2019

Product revenue

 

$

115,000

Cost of product revenue

 

 

141,647

Research and development

 

 

228,641

General and administrative

 

 

79,306

Sales and marketing

 

 

59,431

Impairment (1)

 

 

405,000

Loss on discontinued operations

 

$

(799,025)


(1)Impairment charge was calculated as the net book value of assets held for sale prior to the impairment less the expected net proceeds from the planned sale. The expected net proceeds were based on the estimated fair value of the net assets held for sale less the estimated cost to sell the net assets held for sale. For the year ended December 31, 2019, the Company recorded a loss on the sale of discontinued operations of $9,107.